25 November 2022. Tasmania has raised the official COVID-19 Risk Level to MODERATE as the State continues to experience increases in COVID-19 cases.
Topics
Type
Date
Article
Alert from the State Health Commander for Post COVID-19 Syndrome Navigation Service
An update from the State Health Commander for Post COVID-19 Syndrome Navigation Service.
Article
Changes to isolation requirements
30 September 2022. From 14 October 2022, individuals who have COVID-19 symptoms are encouraged to stay at home while they remain unwell, but it will no longer be mandated for them to remain in isolation for 5 days.
Article
Pharmaceutical Services Branch Newsletter - December 2020
Read about the move to electronically transmitted prescriptions, Poisons List amendments and more in the December 2020 Pharmaceutical Services Branch newsletter.
Article
Pharmaceutical Services Branch Newsletter - March 2020
Read about the impacts of COVID-19, Poisons List amendments and more in the March 2020 Pharmaceutical Services Branch newsletter.
Article
Pharmaceutical Services Branch Newsletter - December 2019
Read about Tasmanian Opioid Pharmacotherapy Program requirements, electronic transmission of prescriptions and more in the December 2019 Pharmaceutical Services Branch newsletter.
Article
Pharmaceutical Services Branch Newsletter - December 2018
Read about poisons legislation amendments, fentanyl prescribing, the keeping of records for narcotic substances and more in the December 2018 Pharmaceutical Services Branch newsletter.
Article
Pharmaceutical Services Branch Newsletter - Codeine Scheduling Changes
Read about Codeine Scheduling Changes in the January 2018 Pharmaceutical Services Branch newsletter.
Article
Pharmaceutical Services Branch Newsletter - Supply of Schedule 4 or Schedule 8 substances
Read about supply by pharmacists of Schedule 4 or Schedule 8 substances without a (hard copy) prescription in the July 2016 Pharmaceutical Services Branch newsletter.